A significant proportion of patients who suffer from atrial fibrillation (AF) and are in need of
thromboembolic protection are not treated with oral anticoagulation or discontinue this …

Atrial fibrillation (AF) is one of the most common arrhythmias seen in clinical cardiology
practice. Patients with non-valvular AF have an approximately 5-fold increase in the risk of …

Left atrial appendage closure is an alternative to chronic oral anticoagulation to prevent
embolic events related to nonvalvular atrial fibrillation. After device implantation …

Transcatheter closure of the left atrial appendage has been developed as an alternative to
chronic oral anticoagulation for stroke prevention in patients with atrial fibrillation, and as a …

It is well established that patients with atrial fibrillation (AF) have a significantly increased
risk of stroke and systemic embolism (SSE). Treatment with oral anticoagulation (OAC) …

Introduction Atrial fibrillation (AF) is associated with an increased risk of stroke, morbidity
and overall mortality. So far, oral anticoagulation (OAC) is the standard of care for stroke …

It is important to prevent on-device thrombus formation without increasing the risk for
bleeding complications after successful interventional left atrial appendage closure …

Atrial fibrillation (AF) is associated with life-threatening thromboembolism. Most emboli stem
from thrombosis in the left atrial appendage (LAA). The current treatment of choice is oral …

Patients with nonvalvular atrial fibrillation have a 4-to 5-fold increase in strokes and that
rhythm may be responsible for 15% to 20% of all strokes, particularly in the elderly. In this …

Atrial fibrillation is the most common cardiac arrhythmia, and its prevalence is increasing.
Cardioembolic stroke, most of the times secondary to thrombus formation in the left atrial …